Illustration of a healthy heart with glowing endothelial lining.

Hidden Threat: Endothelial Dysfunction in Type 2 Diabetes Even with Healthy Arteries

Jordan Keane in Health & Wellness December 2025 • 5 min read.

"New research reveals how diabetes damages blood vessels, increasing heart risks even when arteries appear normal."

Endothelial dysfunction, a stealthy saboteur of cardiovascular health, acts as an early warning sign of atherosclerosis. It foreshadows potential coronary artery disease even before the telltale signs appear on angiograms. Prolonged exposure to cardiovascular risk factors messes with the endothelium, disrupting the production and metabolism of nitric oxide (NO) and ramping up the synthesis of reactive oxygen species (ROS). This leads to compromised endothelial integrity, setting the stage for atherosclerosis, thrombosis, and myocardial ischemia.

Initially identified in hypertensive individuals, endothelial dysfunction has since been found in type 1 and type 2 diabetes, coronary artery disease, and heart failure. Yet, its value as a therapeutic target, like other indicators of organ damage, remains somewhat undefined. Recent studies, however, underscore its role as a predictor of cardiovascular events, independent of coronary lesions. This has made assessing endothelial dysfunction a valuable tool for early risk stratification in patients susceptible to cardiovascular issues.

Consequently, novel non-invasive methods have been developed to assess endothelial function accurately, including flow-mediated dilation (FMD) of the brachial artery and, more recently, peripheral artery tonometry (PAT). These methods provide ways to detect early signs of vascular damage, allowing for more proactive interventions.

What is Peripheral Artery Tonometry (PAT) and Why Is It Important?

Illustration of a healthy heart with glowing endothelial lining.

Peripheral artery tonometry (PAT) is a non-invasive technique used to evaluate endothelial function by measuring the pulsatile volume changes in the digital arteries. This method employs pneumatic probes attached to the fingertips to record these changes, offering a practical way to assess vascular health. PAT measures reactive hyperemia, the increase in blood flow after a period of ischemia, to determine how well the blood vessels are functioning. This is crucial because endothelial dysfunction can be an early indicator of cardiovascular disease.

While FMD has been considered the gold standard for non-invasive assessment of endothelial function, its widespread use is limited by the time required for execution and the expertise needed to perform the tests. PAT offers a more streamlined approach. Recent evidence supports a correlation between reactive hyperemia assessment via PAT and invasive or non-invasive methods of studying endothelial function. Rubinstein et al. demonstrated that endothelial dysfunction, as measured by PAT, could predict cardiovascular events in asymptomatic patients.

Non-Invasive Assessment: PAT provides a non-invasive way to assess endothelial function, making it a safer option than invasive methods.
Predictive Capability: Studies have shown that PAT can predict future cardiovascular events, aiding in early risk stratification.
Correlation with Other Methods: PAT results correlate well with other measures of endothelial function, validating its accuracy.
Streamlined Approach: Compared to FMD, PAT is easier to perform and requires less expertise, making it more accessible.

Given these observations, evaluating endothelial function via PAT could be a valuable tool in cardiovascular risk stratification. Some studies have noted endothelial dysfunction in the early stages of type 2 diabetes (DM) and in first-degree relatives of diabetic patients with reduced insulin sensitivity, but without manifest DM. However, few authors have examined endothelial function in DM patients without angiographic evidence of atherosclerotic disease, and data obtained via PAT have been lacking.

What Does This Mean for Managing Diabetes?

In type 2 diabetes patients, endothelial function is significantly compromised compared to non-diabetic controls, even when other risk factors are similar. This helps explain the pathophysiologic impact of DM on coronary atherosclerosis development and its complications. This study shows that PAT is a valid tool for the early identification of endothelial dysfunction, with potential for use in large populations at cardiovascular risk. The findings support proactive monitoring and management of vascular health in diabetic patients to mitigate long-term cardiovascular risks.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.4081/monaldi.2012.142, Alternate LINK

Title: Endothelial Dysfunction In Type 2 Diabetic Patients With Normal Coronary Arteries. A Peripheral Arterial Tonometry Study

Subject: Cardiology and Cardiovascular Medicine

Journal: Monaldi Archives for Chest Disease

Publisher: PAGEPress Publications

Authors: Donatella Ruggiero, Gianluigi Savarese, Roberto Formisano, Ada Bologna, Giacomo Mattiello, Elisabetta Pirozzi, Francesco Gambardella, Francesco Lo Iudice, Laura Petraglia, Alice Vitagliano, Laura Casaretti, Giuseppe Luca Della Ratta, Susanna Mosca, Pasquale Perrone Filardi

Published: 2015-12-03

Everything You Need To Know

What is endothelial dysfunction and how does it relate to type 2 diabetes?

Endothelial dysfunction is an early warning sign of atherosclerosis, where the endothelium, the inner lining of blood vessels, is compromised. In type 2 diabetes, this dysfunction occurs even when coronary arteries appear normal. Prolonged exposure to cardiovascular risk factors disrupts the production and metabolism of nitric oxide (NO) and increases reactive oxygen species (ROS), leading to compromised endothelial integrity. This sets the stage for atherosclerosis, thrombosis, and myocardial ischemia, thus increasing heart risks. In the context of type 2 diabetes, this dysfunction is especially significant because it can occur before any visible signs of arterial damage.

How does Peripheral Artery Tonometry (PAT) help in assessing cardiovascular risk, and how does it compare to Flow-Mediated Dilation (FMD)?

Peripheral artery tonometry (PAT) is a non-invasive technique used to evaluate endothelial function by measuring pulsatile volume changes in digital arteries. It assesses reactive hyperemia, the increase in blood flow after ischemia. This is crucial as endothelial dysfunction is an early indicator of cardiovascular disease. Unlike Flow-Mediated Dilation (FMD), which is considered the gold standard, PAT offers a more streamlined approach. PAT is easier to perform and requires less expertise. Studies have shown that PAT results correlate well with other measures of endothelial function, making it a valuable tool for cardiovascular risk stratification and a more accessible alternative to FMD.

Why is it important to detect endothelial dysfunction early in type 2 diabetes patients?

Detecting endothelial dysfunction early in type 2 diabetes patients is crucial because it can help identify those at higher risk of future cardiovascular events, even before any signs of atherosclerosis are visible on angiograms. Endothelial dysfunction can be an early sign of vascular damage, it foreshadows potential coronary artery disease, thrombosis, and myocardial ischemia. Early detection allows for proactive monitoring and management of vascular health, which can help mitigate long-term cardiovascular risks associated with diabetes. Since endothelial dysfunction can appear before structural changes in the arteries, early identification is key to implementing timely interventions and reducing the risk of heart problems.

How does the study on endothelial function impact the management of diabetes and cardiovascular health?

The study emphasizes the significance of endothelial dysfunction in type 2 diabetes patients and highlights its role as a predictor of cardiovascular events. The findings support the use of Peripheral Artery Tonometry (PAT) for the early identification of endothelial dysfunction. This proactive approach allows for better monitoring and management of vascular health in diabetic patients to mitigate long-term cardiovascular risks. By detecting endothelial dysfunction early, healthcare providers can implement interventions like lifestyle changes, medication, and targeted therapies that can slow or reverse the progression of vascular damage and improve cardiovascular outcomes.

What are the implications of endothelial dysfunction on the production and metabolism of Nitric Oxide (NO) and Reactive Oxygen Species (ROS) in relation to cardiovascular health?

Endothelial dysfunction disrupts the production and metabolism of Nitric Oxide (NO) and increases the synthesis of Reactive Oxygen Species (ROS). Normally, NO helps in vasodilation and protects against blood vessel damage. When endothelial function is compromised, there is a reduction in NO, leading to impaired vasodilation and increased susceptibility to vasoconstriction. Concurrently, the increased ROS promotes oxidative stress, causing damage to the endothelial cells. This combination of reduced NO bioavailability and increased oxidative stress contributes to the progression of atherosclerosis, thrombosis, and myocardial ischemia, all of which increase the risk of cardiovascular events. Therefore, the balance between NO and ROS is crucial for maintaining endothelial health and preventing cardiovascular complications.